Clearmind Medicine (CMND) - 2024 Q2 - Quarterly Report

18 a. Assets and liabilities measured at fair value on a recurring basis were presented in the Company's statement of financial position as of April 30, 2024, as follows: The fair value of other assets and liabilities, which include cash, amounts receivable, accounts payable and accrued liabilities, and amounts due to related parties, approximate their carrying values due to the relatively short-term maturity of these instruments. Foreign currency risk is the risk that the fair value of future cash flows of ...